638 related articles for article (PubMed ID: 29875409)
1. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice.
Que X; Hung MY; Yeang C; Gonen A; Prohaska TA; Sun X; Diehl C; Määttä A; Gaddis DE; Bowden K; Pattison J; MacDonald JG; Ylä-Herttuala S; Mellon PL; Hedrick CC; Ley K; Miller YI; Glass CK; Peterson KL; Binder CJ; Tsimikas S; Witztum JL
Nature; 2018 Jun; 558(7709):301-306. PubMed ID: 29875409
[TBL] [Abstract][Full Text] [Related]
2. Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospholipids.
Yeang C; Hasanally D; Que X; Hung MY; Stamenkovic A; Chan D; Chaudhary R; Margulets V; Edel AL; Hoshijima M; Gu Y; Bradford W; Dalton N; Miu P; Cheung DY; Jassal DS; Pierce GN; Peterson KL; Kirshenbaum LA; Witztum JL; Tsimikas S; Ravandi A
Cardiovasc Res; 2019 Jan; 115(1):179-189. PubMed ID: 29850765
[TBL] [Abstract][Full Text] [Related]
3. A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice.
Palmieri M; Kim HN; Gomez-Acevedo H; Que X; Tsimikas S; Jilka RL; Manolagas SC; Witztum JL; Ambrogini E
J Bone Miner Res; 2021 Jan; 36(1):170-185. PubMed ID: 32990984
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
[TBL] [Abstract][Full Text] [Related]
5. Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression.
Tsimikas S; Miyanohara A; Hartvigsen K; Merki E; Shaw PX; Chou MY; Pattison J; Torzewski M; Sollors J; Friedmann T; Lai NC; Hammond HK; Getz GS; Reardon CA; Li AC; Banka CL; Witztum JL
J Am Coll Cardiol; 2011 Oct; 58(16):1715-27. PubMed ID: 21982317
[TBL] [Abstract][Full Text] [Related]
6. Oxidation-specific epitopes restrain bone formation.
Ambrogini E; Que X; Wang S; Yamaguchi F; Weinstein RS; Tsimikas S; Manolagas SC; Witztum JL; Jilka RL
Nat Commun; 2018 Jun; 9(1):2193. PubMed ID: 29875355
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis.
Sun X; Seidman JS; Zhao P; Troutman TD; Spann NJ; Que X; Zhou F; Liao Z; Pasillas M; Yang X; Magida JA; Kisseleva T; Brenner DA; Downes M; Evans RM; Saltiel AR; Tsimikas S; Glass CK; Witztum JL
Cell Metab; 2020 Jan; 31(1):189-206.e8. PubMed ID: 31761566
[TBL] [Abstract][Full Text] [Related]
8. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
[TBL] [Abstract][Full Text] [Related]
9. Novel Autoimmune IgM Antibody Attenuates Atherosclerosis in IgM Deficient Low-Fat Diet-Fed, but Not Western Diet-Fed
Cherepanova OA; Srikakulapu P; Greene ES; Chaklader M; Haskins RM; McCanna ME; Bandyopadhyay S; Ban B; Leitinger N; McNamara CA; Owens GK
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):206-219. PubMed ID: 31645128
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression.
Tsimikas S; Aikawa M; Miller FJ; Miller ER; Torzewski M; Lentz SR; Bergmark C; Heistad DD; Libby P; Witztum JL
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):175-81. PubMed ID: 17082490
[TBL] [Abstract][Full Text] [Related]
11. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
12. Cloning and expression of an anti-LDL(-) single-chain variable fragment, and its inhibitory effect on experimental atherosclerosis.
Kazuma SM; Cavalcante MF; Telles AE; Maranhão AQ; Abdalla DS
MAbs; 2013; 5(5):763-75. PubMed ID: 23924793
[TBL] [Abstract][Full Text] [Related]
13. Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr
Jeurissen MLJ; Walenbergh SMA; Houben T; Gijbels MJJ; Li J; Hendrikx T; Oligschlaeger Y; van Gorp PJ; Binder CJ; Donners MMPC; Shiri-Sverdlov R
Atherosclerosis; 2016 Dec; 255():59-65. PubMed ID: 27816810
[TBL] [Abstract][Full Text] [Related]
14. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
[TBL] [Abstract][Full Text] [Related]
15. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism.
Zhou X; He W; Huang Z; Gotto AM; Hajjar DP; Han J
J Biol Chem; 2008 Jan; 283(4):2129-38. PubMed ID: 18029360
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.
Zheng KH; Tsimikas S; Pawade T; Kroon J; Jenkins WSA; Doris MK; White AC; Timmers NKLM; Hjortnaes J; Rogers MA; Aikawa E; Arsenault BJ; Witztum JL; Newby DE; Koschinsky ML; Fayad ZA; Stroes ESG; Boekholdt SM; Dweck MR
J Am Coll Cardiol; 2019 May; 73(17):2150-2162. PubMed ID: 31047003
[TBL] [Abstract][Full Text] [Related]
17. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
[TBL] [Abstract][Full Text] [Related]
18. The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity.
Tsimikas S; Witztum JL
Curr Opin Lipidol; 2008 Aug; 19(4):369-77. PubMed ID: 18607184
[TBL] [Abstract][Full Text] [Related]
19. Targeting oxidized phospholipids by AAV-based gene therapy in mice with established hepatic steatosis prevents progression to fibrosis.
Upchurch CM; Yeudall S; Pavelec CM; Merk D; Greulich J; Manjegowda M; Raghavan SS; Bochkis IM; Scott MM; Perez-Reyes E; Leitinger N
Sci Adv; 2022 Jul; 8(28):eabn0050. PubMed ID: 35857497
[TBL] [Abstract][Full Text] [Related]
20. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.
Trpkovic A; Resanovic I; Stanimirovic J; Radak D; Mousa SA; Cenic-Milosevic D; Jevremovic D; Isenovic ER
Crit Rev Clin Lab Sci; 2015; 52(2):70-85. PubMed ID: 25537066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
